Trial Profile
Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With Relapsing-remitting and Secondary-progressive Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2020
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 06 Jul 2007 New trial record.